About Us

Kevin M. Egan, MBA, President, has 30 years experience in the biotechnology industry.  Most recently he was Vice President, Business Development for CMC Biologics where he led US Business Development efforts. Prior to this Mr. Egan worked for ICOS Corp. in various business development capacities including Senior Director, Operations Contracts & Licensing.  In addition to negotiating licensing, partnering, and outsourcing agreements for both biologics and small molecules he was responsible for building and running ICOS’ biologics manufacturing business including marketing, business development, and managing the P&L. Over the course of his career Mr. Egan has negotiated and closed over 100 contracts and agreements with companies from the U.S., Canada, Europe, Australia, Israel, Japan and Taiwan.   To date he has brought in over $150M in revenue for various contract manufacturing organizations. 


Mr. Egan began his career at Amgen, Inc. where he worked in research for ten years. He has helped develop and launch three blockbuster products during the course of his career - Epogen and Neupogen at Amgen; and Cialis at ICOS. 


Mr. Egan has an MBA from the University of Washington, a Master’s degree in Biochemistry and Molecular Biology from U.C. Santa Barbara, and undergraduate degrees in Biology and Chemistry from U.C. Santa Cruz.